Seminars in Oncology
Volume 29, Issue 4 , Pages 328-335 , August 2002

Surgical techniques of melanoma and sentinel node biopsy

References 

  1. Karakousis CP, Balch CM, Urist MM, et al.  Local recurrence in malignant melanoma: Long-term results of the multiinstitutional randomized surgical trial. Ann Surg Oncol. 1996;3:446–452
  2. Veronesi U, Cascinelli N. Narrow excision (1-cm margin). A safe procedure for thin cutaneous melanoma. Arch Surg. 1991;126:438–441
  3. Heaton KM, Sussman JJ, Gershenwald JE, et al.  Surgical margins and prognostic factors in patients with thick (>4 mm) primary melanoma. Ann Surg Oncol. 1998;5:322–328
  4. Cascinelli N, van der Esch EP, Breslow A, et al.  WHO Collaborating Centres for Evaluation of Methods of Diagnosis and Treatment of Stage I Melanoma of the Skin: The problem of resection margins. Eur J Cancer. 1980;16:1079–1085
  5. Whooley BP, Wallack MK. Surgical management of melanoma. Surg Oncol. 1995;4:187–195
  6. Ross MI. Surgery and other local-regional modalities for all stages of melanoma. Curr Opin Oncol. 1994;6:197–201
  7. Hochwald S, Coit DG. Role of elective lymph node dissection in melanoma. Semin Surg Oncol. 1998;14:276–282
  8. Kroon BBR, Nieweg OE, Hoekstra HJ. Principles and guidelines for surgeons: Management of cutaneous malignant melanoma. Eur J Surg Oncol. 1997;23:550–558
  9. Balch C, Soong SJ, Bartolucci AA, et al.  Efficacy of an elective regional lymph node dissection of 1 to 4 mm thick melanomas for patients 60 years of age and younger. Ann Surg. 1996;224:255–266
  10. Veronesi U, Adamus J, Bandiera DC, et al.  Delayed regional lymphnode dissection in stage I melanoma of the skin of the lower extremities. Cancer. 1982;49:2420–2430
  11. Veronesi U, Adamus J, Bandiera DC, et al.  Inefficacy of immediate node dissection in stage I melanoma of the limbs. N Engl J Med. 1977;297:627–630
  12. Veronesi U, Adamus J, Bandiera DC, et al.  Stage I melanoma of the limbs. Immediate versus delayed node dissection. Tumori. 1980;66:373–396
  13. Sim FH, Tailor WF, Pritchard DJ, et al.  Lymphadenectomy in the management of stage I malignant melanoma: A prospective randomized study. Mayo Clin Proc. 1986;61:697–705
  14. Ross MI, Reintgen DS, Balch CM. Selective lymphadenectomy: The emerging role of lymphatic mapping and sentinel node biopsy in the management of early stage melanoma. Semin Surg Oncol. 1993;9:219–223
  15. Papachristou D, Fortner JG. Comparison of lymphedema following in-continuity and discontinuity groin dissection. Ann Surg. 1977;185:13
  16. Ross MI. Surgical management of stage I and II melanoma patients: Approach to the regional lymph node basin. Semin Surg Oncol. 1996;12:394–401
  17. Handley WS. The pathology of melanotic growths in relation to their operative treatment. Lancet. 1907;1:927–935
  18. Australian Cancer Network . Guidelines for the Management of Cutaneous Melanoma. Epping, Australia,: Stone Press; June 1997;
  19. Nitsche N, Hoffmann K, Iro H. Ultrasound diagnosis of skin tumors. HNO Berlin. 1992;40:97–100
  20. Shafir R, Itzchaky H, Hemanz Z, et al.  Preoperative ultrasonic measurement of thickness of cutaneous malignant melanoma. J Ultrasound Med. 1984;3:205–208
  21. Stanganelli I, Zago S, Testori A, et al.  Epiluminescence microscopy features of melanoma in relation to tumor thickness current concepts and clinical examples. Dermatol Clin. 2001;19:285–297
  22. Balch CM, Buzaid AC, Soong SJ, et al.  Final version of the American Joint Committee on Cancer Staging System for Cutaneous Melanoma. J Clin Oncol. 2001;19:3635–3648
  23. Balch CM, Buzaid AC, Atkins MB, et al.  A new American Joint Committee on Cancer staging system for cutaneous melanoma. Cancer. 2000;88:1484–1491
  24. Balch CM, Soong SJ, Greshenwald JE, et al.  Prognostic factors analysis of 17600 melanoma patients: Validation of the American Joint Committee on Cancer staging system. J Clin Oncol. 2001;19:3622–3634
  25. Ruiter D, Testori A, Eggermont A, et al.  The AJCC staging proposal for cutaneous melanoma: Comments by the EORTC Melanoma Group. Ann Oncol. 2001;12:9–11
  26. Morton DL, Thompson JF, Mozzillo N, et al.  Validation of the accuracy of intraoperative lymphatic mapping and sentinel-lymphadenectomy for early-stage melanoma—A multicenter trial. Ann Surg. 1999;230:453–465
  27. Morton DL, Wen DR, Wong JH, et al.  Technical details of intraoperative lymphatic mapping for early stage melanoma. Arch Surg. 1992;127:392–399
  28. Morton DL, Wen DR, Cochran AJ. Managment of early stage melanoma by intraoperative lymphatic mapping and selective lymphoadenectomy: An alternative to routine lymphoadenectomy or “watch and wait ”. Surg Oncol Clin North Am. 1992;1:247–259
  29. Wong JH, Cagle LA, Morton DL. Lymphatic drainage of shin to sentinel node in a feline model. Ann Surg. 1991;214:637–641
  30. Wong JH, Truelove K, Ko P, et al.  Localization and resection of an in transit sentinel lymph node by use of lymphoscintigraphy, intraoperative lymphatic mapping, and a hand-held gamma probe. Surgery. 1996;120:114–116
  31. Bartolomei M, Testori A, Chinol M, et al.  Sentinel node localisation in cutaneous melanoma: Lymphoscintigraphy with colloids and antibody fragments versus blue dye mapping. Eur J Nucl Med. 1998;25:1489–1494
  32. Testori A, Bartolomei M, Grana C. Sentinel node localisation in primary melanoma: learning curve and results. Melanoma Res. 1999;9:587–593
  33. Thompson JF, McCarthy WH, Bosch CMJ, et al.  Sentinel lymph node status as indicator of the presence of metastatic melanoma in regional lymph nodes. Melanoma Res. 1995;5:255–260
  34. Godellas CV, Berman CG, Lyman G, et al.  The identification and mapping of melanoma regional nodal metastases: Minimally invasive surgery for the diagnosis of nodal metastases. Am Surg. 1995;61:97–101
  35. Krag DN, Sybern JM, Weaver DL, et al.  Minimal-access surgery for staging of malignant melanoma. Arch Surg. 1995;130:654–658
  36. Leong SPL, Stenmetz I, Habib FA, et al.  Optimal selective sentinel lymph node dissection in primary malignant melanoma. Arch Surg. 1997;132:666–673
  37. Lingam MK, Mackie RM, Mackay AJ. Intraoperative lymphatic mapping using patent blue V dye to identify nodal micrometastases in malignant melanoma. Reg Cancer Treat. 1994;7:144–146
  38. Pijpers R, Collet JG, Meijer S, et al.  The impact of dynamic lymphoscintigraphy and gamma probe guidance on sentinel node biopsy in melanoma. Eur J Nucl Med. 1995;22:1238–1241
  39. Van der Veen H, Hoekstra OS, Paul MA, et al.  Gamma probe guided sentinel node biopsy to select patients with melanoma for lymphadenectomy. Br J Surg. 1994;81:1769–1770
  40. Krag D, Harlow S, Weaver D, et al.  Technique of sentinel node resection in melanoma and breast cancer: Probe-guided surgery and lymphatic mapping. Eur J Surg Oncol. 1998;24:89–93
  41. Karakousis CP, Najibi S, Trunk J. Sentinel node biopsy in malignant melanoma. J Surg Oncol. 1997;66:282–284
  42. Testori A. Sentinel node biopsy. Melanoma Res. 1999;9:619–620 (letter)
  43. Testori A, Baldini F, Pelliccia L. Sentinel node biopsy on melanoma patients under local anaesthesia: Is it worthwhile?. Eur J Cancer. 2001;37(suppl 2):115–116
  44. Kapteijn BAE, Nieweg OE, Liem I, et al.  Localising the sentinel node in cutaneous melanoma: Gamma probe detection versus blue dye. Ann Surg Oncol. 1997;4:156–160
  45. Wells KE, Rapaport DP, Cruse CW, et al.  Sentinel lymph node biopsy in melanoma of the head and neck. Plast Reconstr Surg. 1997;100:591–594
  46. Rivers KJ, Roof MI. Sentinel lymph-node biopsy in melanoma: Is less surgery better?. Lancet. 1997;350:1336–1337
  47. Cascinelli N, Belli F, Santinami M, et al.  Sentinel lymph node biopsy in cutaneous melanoma: The WHO melanoma program experience. Ann Surg Oncol. 2000;7:469–474
  48. Emilia JC, Lawrence WJ. Sentinel lymph node biopsy in malignant melanoma: The standard of care?. J Surg Oncol. 1997;65:153–154
  49. Karakousis CP. Ilioinguinal lymph node dissection. Am J Surg. 1981;141:299–304

☆ Address reprint requests to Alessandro Testori, MD, Co-director, Divisione di Chirurgia Generale, Head Unità Melanoma, Istituto Europeo di Oncologia, via Ripamonti 435, 20141 Milano, Italy.

PII: S0093-7754(02)50262-1

doi: 10.1053/sonc.2002.34110

Seminars in Oncology
Volume 29, Issue 4 , Pages 328-335 , August 2002

Article Tools

* Image Usage & Resolution